Resapp release...Dr Michael stein is currently acting CEO of immuno-oncology company, Valo Therapeutics. Immediately prior to Valo, Michael was the founding CEO of OxStem Ltd, an award-winning biotechnology spin-out from the University of Oxford. Michael previously served as founding CEO for Doctor Care Anywhere, a UK-based telemedicine platform acquired by Synergix in 2015
https://www.copyright link/street-talk/uk-s-doctor-care-anywhere-joins-the-asx-healthtech-party-20200813-p55l85
This was picked up but not linked to our board member So I’ve reposted it.
- Forums
- ASX - By Stock
- RAP media thread.
Resapp release...Dr Michael stein is currently acting CEO of...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 1,975 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)